Screener — stockrow

HCA Healthcare, Inc.

HCA Healthcare · Medical Care Facilities · US

$496.04 +5.24% 1Y

Low $353.99 High $556.52

HCA Healthcare is a U.S. health-care services company that operates hospitals and outpatient facilities. It provides medical care to patients, while payments commonly come from Medicare, Medicaid, managed-care plans, private insurers and patients themselves.

Market cap $106.0B

Revenue growth (Q) +3.59%

EPS growth (Q) +22.3%

FCF growth (Q) −0.77%

Revenue growth (next yr) +4.67%

Net margin 8.61%

ROE −200.5%

P/E 15.7×

Forward P/E 15.6×

P/FCF 17.8×

Dividend yield 0.62%

Insider ownership 35.0%

Insider buys / sells (12M) — $29.3M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$60.2B	$65.0B	$70.6B	$75.6B	$78.7B
EPS	$19.15	$18.97	$22.00	$28.33	$31.42
Free cash flow	$4.1B	$4.7B	$5.6B	$7.7B	$6.0B
Net debt	$37.2B	$38.7B	$41.1B	$45.5B	$49.6B

Tenet Healthcare Corporation

THC Healthcare · Medical Care Facilities · US

$283.93 +39.1% 1Y

Low $157.58 High $301.44

Tenet Healthcare is a healthcare services company headquartered in Dallas, Texas. Saum Sutaria is its chairman and chief executive officer.

Market cap $22.8B

Revenue growth (Q) +6.47%

EPS growth (Q) +291.8%

FCF growth (Q) +39.2%

Revenue growth (next yr) +5.34%

Net margin 13.1%

ROE 43.9%

P/E 7.6×

Forward P/E 7.5×

P/FCF 6.8×

Dividend yield —

Insider ownership 1.63%

Insider buys / sells (12M) — $62.9M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$19.2B	$20.6B	$20.7B	$21.3B	$22.2B
EPS	$3.79	$5.71	$32.70	$15.49	$37.19
Free cash flow	$321.0M	$1.6B	$1.1B	$2.5B	$3.3B
Net debt	$14.2B	$13.8B	$10.2B	$10.3B	$10.6B

Encompass Health Corporation

EHC Healthcare · Medical Care Facilities · US

$137.46 +19.5% 1Y

Low $92.77 High $143.36

Encompass Health operates inpatient rehabilitation hospitals for people recovering from major illnesses or injuries. Its patients receive intensive therapy and nursing care while staying in a hospital, with the aim of regaining physical and cognitive abilities and becoming more independent.

Market cap $13.9B

Revenue growth (Q) +8.93%

EPS growth (Q) +21.0%

FCF growth (Q) +52.3%

Revenue growth (next yr) +9.06%

Net margin 10.2%

ROE 19.4%

P/E 21.2×

Forward P/E 20.9×

P/FCF 31.6×

Dividend yield 0.57%

Insider ownership 0.66%

Insider buys / sells (12M) — $47.8M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$4.3B	$4.8B	$5.4B	$5.9B	$6.3B
EPS	$2.70	$3.47	$4.46	$5.54	$6.40
Free cash flow	$111.6M	$267.7M	$360.3M	$439.2M	$457.2M
Net debt	$2.7B	$2.6B	$2.4B	$2.4B	$2.5B

Fresenius Medical Care AG & Co. KGaA

FMS Healthcare · Medical Care Facilities · DE

$23.32 −4.03% 1Y

Low $20.02 High $26.42

Fresenius Medical Care AG & Co. KGaA (FMS) is a global leader in providing products and services for individuals with chronic kidney failure.

Market cap $12.6B

Revenue growth (Q) −0.49%

EPS growth (Q) −10.6%

FCF growth (Q) −3.47%

Revenue growth (next yr) −38.2%

Net margin 4.18%

ROE 5.90%

P/E 12.5×

Forward P/E 14.4×

P/FCF 6.0×

Dividend yield 3.74%

Insider ownership 0.00%

Insider buys / sells (12M) — —

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$20.4B	$21.1B	$20.9B	$22.2B	$22.6B
EPS	$1.21	$0.92	$0.98	$1.90	$1.87
Free cash flow	$1.6B	$2.1B	$1.8B	$2.0B	$2.0B
Net debt	$7.6B	$6.8B	$5.1B	$6.0B	$7.0B

DaVita Inc.

DVA Healthcare · Medical Care Facilities · US

$191.21 +57.3% 1Y

Low $101.00 High $247.49

DaVita provides kidney care, principally dialysis for people whose kidneys have failed. Dialysis removes waste, salt and excess fluid from the blood when the kidneys can no longer do so.

Market cap $12.3B

Revenue growth (Q) +4.62%

EPS growth (Q) +101.6%

FCF growth (Q) −45.8%

Revenue growth (next yr) +3.77%

Net margin 6.49%

ROE −277.7%

P/E 13.1×

Forward P/E 13.0×

P/FCF 8.2×

Dividend yield —

Insider ownership 3.52%

Insider buys / sells (12M) — $523.4M

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$11.6B	$12.1B	$12.8B	$13.6B	$14.2B
EPS	$5.85	$7.42	$10.73	$9.84	$14.29
Free cash flow	$1.1B	$1.6B	$1.5B	$1.3B	$1.3B
Net debt	$8.5B	$7.9B	$8.5B	$9.7B	$10.2B

Stockrow Weekly